Pharma Insight ApS: Financial statements 2021
CVR: 40637117
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Pharma Insight ApS (CVR 40637117) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 725,062 and a net result of DKK 47,936. Equity in the 2021 report amounted to DKK 272,817. The solvency ratio was 66.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 725,062
- Profit/Loss
- DKK 47,936
- Equity
- DKK 272,817
- Total Assets
- DKK 409,029
- Employees
- 1
Official annual report
Find more companies like Pharma Insight ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Pharma Insight ApS has published its interim report for the period July 1, 2019 – December 31, 2020.
About Pharma Insight ApS
Pharma Insight ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2019. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Marianne Kock and Peter Kock. The company is owned by Peter Kock Holding ApS. The company has 1 employee (2021). In 2025, the company reported a gross profit of DKK 342,207 and a net result of DKK 265,159 compared with DKK 117,750 the year before. Equity in the 2025 report amounted to DKK 340,254.